Bortezomib lyophilized powder for injection and preparation process thereof
A technology of bortezomib and freeze-dried powder injection, applied in the field of medicine, can solve the problems of poor solubility of bortezomib raw materials, and achieve the effects of reducing dissolution time, reducing usage, and high product qualification rate
Active Publication Date: 2019-02-22
KINDOS PHARM CO LTD
View PDF6 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0005] In view of the above technical problems, the present invention provides a bortezomib freeze-dried powder for injection, which solves the problem of poor solubility of bortezomib raw materials and improves the stability of intermediate products and preparations
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0024] A bortezomib freeze-dried powder for injection, by weight, comprises the following raw materials:
[0025]
Embodiment 2
[0027] A bortezomib freeze-dried powder for injection, by weight, comprises the following raw materials:
[0028]
Embodiment 3
[0030] A bortezomib freeze-dried powder for injection, by weight, comprises the following raw materials:
[0031]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention provides bortezomib lyophilized powder for injection. The bortezomib lyophilized powder for injection comprises the following raw materials in parts by weight: 0.1 to 0.3 part of bortezomib, 3 to 10 parts of acetonitrile, 1 to 3 parts of mannitol and 87 to 94 parts of water. A preparation process comprises the following steps: fully dissolving the raw material medicines in an acetonitrile-aqueous solution, and then putting the mixed solution into the auxiliary material, namely a mannitol solution; the bortezomib is in sufficient contact with the mannitol solution in a dissolved state to rapidly form boric acid ester, so that the problem of poor solubility of the bortezomib raw material is solved under the premise of small use amount of an organic solvent, and the stability ofan intermediate product and a preparation is improved.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a bortezomib freeze-dried powder for injection. Background technique [0002] Bortezomib is a new type of antineoplastic drug, trade name Velcade, developed by Millennium Pharmaceutical Company of the United States. The solubility of the bulk drug of bortezomib in water is only 0.52mg / ml, and the solubility of the bulk drug is low, which cannot reach the prescription concentration. Therefore, it is necessary to use an appropriate co-solvent, and on this basis to obtain a finished preparation with good stability. [0003] Chinese patent CN102784114, a bortezomib freeze-dried powder injection and its preparation method, by mixing and grinding bortezomib and excipients, the two are fully contacted and mixed to promote the dissolution of the raw material bortezomib, and at the same time add antioxidants to increase its stability. Chinese patent CN103142509, the composition contai...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K47/26A61K47/16A61K38/05A61K31/69A61P35/00
CPCA61K9/0019A61K9/19A61K31/69A61K38/05A61K47/16A61K47/26A61P35/00
Inventor 李娜王靖李方年
Owner KINDOS PHARM CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com